CHI3L1 and myeloid sarcoma: Furthermore, we found that the cut off value in CSF CHI3L1 between RRMS and progressive MS was 154 ng/ml, and our results are near to these of other studies as that of Modvig and colleagues in 2015 in which the cut off value for progression was 147 ng/ml.